Nitrogen mustard vincristine procarbazine prednisone adjuvant chemotherapy treatment medulloblastoma Pediatric Oncology Group study randomized postoperative trial adjuvant post-irradiation chemotherapy nitrogen mustard vincristine procarbazine prednisone MOPP versus radiation therapy medulloblastoma patients years age Patients irradiation MOPP significant increase overall survival rate years posttreatment patients radiation therapy race gender overall study significant advantage irradiation MOPP event-free survival statistical significance children years age severe hematological toxicities group irradiation MOPP hematotoxicity tolerable acceptable results patients irradiation chemotherapy surgery medulloblastoma 